{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-009051","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2022-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.269452+00:00","generated_at":"2026-06-26T10:03:37.269775+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Oncotelic issues $0.25M convertible note to Fourth Man, LLC at 12% interest","bullets":["Convertible promissory note principal $0.25M, 12% annual interest, matures in one year.","Conversion price fixed at $0.10 per share; also issued 1,250,000 warrants at $0.20 exercise.","Finder's fee to JH Darbie: 10% of gross proceeds plus warrants equal to 10% of amount raised.","Proceeds for general working capital and repayment of certain debt; same terms as November 2021 issuances."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-009051","json":"https://secwatch.observer/filing/0001493152-22-009051.json","markdown":"https://secwatch.observer/filing/0001493152-22-009051.md","text":"https://secwatch.observer/filing/0001493152-22-009051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315222009051/0001493152-22-009051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315222009051/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T10:03:37.269775+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}